Jan Klapproth

750 total citations
9 papers, 639 citations indexed

About

Jan Klapproth is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Jan Klapproth has authored 9 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Jan Klapproth's work include Escherichia coli research studies (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Immune Response and Inflammation (2 papers). Jan Klapproth is often cited by papers focused on Escherichia coli research studies (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Immune Response and Inflammation (2 papers). Jan Klapproth collaborates with scholars based in Germany, United States and Switzerland. Jan Klapproth's co-authors include Tilo Andus, Peter C. Heinrich, Thomas Geiger, Toshio Hirano, T Kishimoto, Michael S. Donnenberg, John Abraham, S. P. James, José V. Castell and Harry L. T. Mobley and has published in prestigious journals such as Infection and Immunity, European Journal of Biochemistry and European Journal of Immunology.

In The Last Decade

Jan Klapproth

9 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Klapproth Germany 8 204 197 112 93 78 9 639
Kunal P. Patel United States 12 190 0.9× 173 0.9× 185 1.7× 125 1.3× 57 0.7× 15 723
Mark A. Pilkinton United States 15 255 1.3× 295 1.5× 127 1.1× 169 1.8× 111 1.4× 23 835
Megumi Takahashi Japan 15 121 0.6× 196 1.0× 70 0.6× 78 0.8× 33 0.4× 45 749
Kangkang Yang China 10 351 1.7× 253 1.3× 85 0.8× 91 1.0× 42 0.5× 18 674
Hisae Karahashi Japan 13 405 2.0× 291 1.5× 114 1.0× 77 0.8× 33 0.4× 17 871
Colleen S. Curran United States 16 247 1.2× 246 1.2× 86 0.8× 142 1.5× 70 0.9× 29 779
Ryan Crane United States 11 239 1.2× 218 1.1× 125 1.1× 36 0.4× 46 0.6× 20 710
Shingi Nakae Japan 6 292 1.4× 304 1.5× 134 1.2× 91 1.0× 66 0.8× 13 795
Kanji Tsuchimoto Japan 18 157 0.8× 263 1.3× 260 2.3× 100 1.1× 82 1.1× 82 906
Elisabeth G. Foerster Canada 7 237 1.2× 305 1.5× 178 1.6× 52 0.6× 44 0.6× 9 641

Countries citing papers authored by Jan Klapproth

Since Specialization
Citations

This map shows the geographic impact of Jan Klapproth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Klapproth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Klapproth more than expected).

Fields of papers citing papers by Jan Klapproth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Klapproth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Klapproth. The network helps show where Jan Klapproth may publish in the future.

Co-authorship network of co-authors of Jan Klapproth

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Klapproth. A scholar is included among the top collaborators of Jan Klapproth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Klapproth. Jan Klapproth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Klapproth, Jan, Thomas Rexer, Steffen Klamt, et al.. (2018). Establishment of a five-enzyme cell-free cascade for the synthesis of uridine diphosphate N-acetylglucosamine. Journal of Biotechnology. 283. 120–129. 33 indexed citations
2.
Rexer, Thomas, Jan Klapproth, Angelika Schierhorn, et al.. (2017). One pot synthesis of GDP‐mannose by a multi‐enzyme cascade for enzymatic assembly of lipid‐linked oligosaccharides. Biotechnology and Bioengineering. 115(1). 192–205. 41 indexed citations
3.
Rahman, Khalidur, Maiko Sasaki, Asma Nusrat, & Jan Klapproth. (2014). Crohnʼs Disease–associated Escherichia coli Survive in Macrophages by Suppressing NFκB Signaling. Inflammatory Bowel Diseases. 20(8). 1419–1425. 15 indexed citations
4.
Klapproth, Jan, et al.. (2009). Lymphostatin – ein Multitalent. DMW - Deutsche Medizinische Wochenschrift. 134(9). 417–420. 1 indexed citations
5.
Klapproth, Jan, Michael S. Donnenberg, John Abraham, & S. P. James. (1996). Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 271(5). G841–G848. 36 indexed citations
6.
Klapproth, Jan, Michael S. Donnenberg, John Abraham, Harry L. T. Mobley, & S. P. James. (1995). Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infection and Immunity. 63(6). 2248–2254. 53 indexed citations
7.
Castell, José V., Jan Klapproth, Volker Groß, et al.. (1990). Fate of interleukin‐6 in the rat. European Journal of Biochemistry. 189(1). 113–118. 46 indexed citations
8.
Klapproth, Jan, José V. Castell, Thomas Geiger, Tilo Andus, & Peter C. Heinrich. (1989). Fate and biological action of human recombinant interleukin 1β in the rat in vivo. European Journal of Immunology. 19(8). 1485–1490. 59 indexed citations
9.
Geiger, Thomas, Tilo Andus, Jan Klapproth, et al.. (1988). Induction of rat acute‐phase proteins by interleukin 6 in vivo. European Journal of Immunology. 18(5). 717–721. 355 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026